Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Eller

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
JCI Insight|April 20, 2017
T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 responseJames J Knox, Marcus Buggert, Lela Kardava, et al.
Journal of Virology|September 14, 2018
Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in HumansFranco Pissani, Bianca Schulte, Michael A Eller, et al.
Elife|November 6, 2016
A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in UgandaFrançois Blanquart, Mary Kate Grabowski, Joshua Herbeck, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2014
Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individualsHaitao Hu, Michael A Eller, Shah Zafar, et al.
The Lancet. Infectious Diseases|April 26, 2015
Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort studyDanielle V Clark, Hannah Kibuuka, Monica Millard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2009
Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infectionMichael A Eller, Leigh Anne Eller, Benson J Ouma, et al.
Journal of Clinical Microbiology|August 19, 2007
Large-scale human immunodeficiency virus rapid test evaluation in a low-prevalence ugandan blood bank populationLeigh A Eller, Michael A Eller, Benson J Ouma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2013
Differential loss of invariant natural killer T cells and FoxP3⁺ regulatory T cells in HIV-1 subtype A and subtype D infectionsBritta Flach, Prossy Naluyima, Kim Blom, et al.
Frontiers in Immunology|June 7, 2021
Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus SurvivorsDominic Paquin-Proulx, Bronwyn M Gunn, Aljawharah Alrubayyi, et al.
AIDS (London, England)|November 26, 2019
Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ARTMichael A Eller, Ting Hong, Matthew Creegan, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
JCI Insight|April 20, 2017
T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 responseJames J Knox, Marcus Buggert, Lela Kardava, et al.
Journal of Virology|September 14, 2018
Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in HumansFranco Pissani, Bianca Schulte, Michael A Eller, et al.
Elife|November 6, 2016
A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in UgandaFrançois Blanquart, Mary Kate Grabowski, Joshua Herbeck, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2014
Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individualsHaitao Hu, Michael A Eller, Shah Zafar, et al.
The Lancet. Infectious Diseases|April 26, 2015
Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort studyDanielle V Clark, Hannah Kibuuka, Monica Millard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2009
Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infectionMichael A Eller, Leigh Anne Eller, Benson J Ouma, et al.
Journal of Clinical Microbiology|August 19, 2007
Large-scale human immunodeficiency virus rapid test evaluation in a low-prevalence ugandan blood bank populationLeigh A Eller, Michael A Eller, Benson J Ouma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2013
Differential loss of invariant natural killer T cells and FoxP3⁺ regulatory T cells in HIV-1 subtype A and subtype D infectionsBritta Flach, Prossy Naluyima, Kim Blom, et al.
Frontiers in Immunology|June 7, 2021
Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus SurvivorsDominic Paquin-Proulx, Bronwyn M Gunn, Aljawharah Alrubayyi, et al.
AIDS (London, England)|November 26, 2019
Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ARTMichael A Eller, Ting Hong, Matthew Creegan, et al.
Pageof 9